Literature DB >> 946488

Pharmacokinetics in clinical practice. I. Concepts.

M Gibaldi, G Levy.   

Abstract

Important concepts of pharmacokinetics, such as the biologic half-life, clearance, and bioavailability of drugs, can be utilized to describe and predict the time course of drug concentrations in plasma as a function of dose and frequency of drug administration. In quantitative terms, they can serve to characterize the individuality of the patient, including the effects of disease, with respect to drug absorption, distribution, excretion, and metabolism.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 946488

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  5 in total

1.  Perspectives on the history and scientific contributions of Gerhard Levy.

Authors:  Ho-Leung Fung; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-24       Impact factor: 2.745

2.  Xanthines in respiratory diseases.

Authors:  J A Mazza
Journal:  Can Fam Physician       Date:  1982-10       Impact factor: 3.275

3.  Clinical pharmacokinetics: a simplified approach, Part 1.

Authors:  E Perlin; R E Taylor; C Peck
Journal:  J Natl Med Assoc       Date:  1985-06       Impact factor: 1.798

4.  Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and postprandial states in man.

Authors:  T Ishizaki; T Nomura; T Abe
Journal:  J Pharmacokinet Biopharm       Date:  1979-08

5.  Computational screening of natural compounds from Salvia plebeia R. Br. for inhibition of SARS-CoV-2 main protease.

Authors:  Afraa Aqeel Zackria; Ramya Pattabiraman; T P Krishna Murthy; S Birendra Kumar; Blessy Baby Mathew; Vinai George Biju
Journal:  Vegetos       Date:  2021-10-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.